Signaling pathways
- BA2913 XZ739Summary: XZ739 is a degrading agent.
- BA2914 hnRNPK-IN-1Summary: hnRNPK-IN-1 is a heterogeneous ribonucleoprotein K-binding ligand with values of 4.6 μM and 2.6 μM measured by SPR and MST, respectively.
- BA2915 DesoxyrhaponticinSummary: Desoxyrhaponticin is an orally effective fatty acid synthase inhibitor with apoptotic effects on human cancer cells.
- BA2916 JNJ-1013Summary: JNJ-1013 is an effective selective degrader.
- BA2917 α-SolanineSummary: Alpha-solanine is a biologically active ingredient in.
- BA2918 INCB-057643Summary: INCB-057643 is a new type.
- BA2919 ImifoplatinSummary: Imifoplatin (PT-112) is a platinum-based active molecule belonging to the phosphoplatinum family.
- BA2920 CustirsenSummary: Custirsen is a highly specific antisense oligonucleotide.
- BA2921 A-192621Summary: A-192621 is a potent non-peptide, orally active, selective endothelin B receptor antagonist.
- BA2924 AK-778-XXMUSummary: AK-778-XXMU is a potent inhibitor of DNA binding 2 antagonists.